91
Participants
Start Date
November 30, 2013
Primary Completion Date
September 30, 2018
Study Completion Date
September 30, 2018
Rivastigmine
Capsule. Dose 3,0 - 6,0 mg BID
Placebo (for rivastigmine)
Capsule. Dose 3,0 - 6,0 mg BID
Academic Medical Center, Amsterdam
University Medical Center Groningen, Groningen
Atrium Medical Center, Heerlen
University Medical Center St Radboud, Nijmegen
Collaborators (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Atrium Medical Center
OTHER
University Medical Center Groningen
OTHER
Leiden University Medical Center
OTHER
University Medical Center Nijmegen
OTHER
International Parkinson Fonds Germany GmbH
INDUSTRY
ZonMw: The Netherlands Organisation for Health Research and Development
OTHER
Amsterdam UMC, location VUmc
OTHER